Valicenti Advisory Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-47,583
Closed -$3.58M 80
2021
Q1
$3.58M Sell
47,583
-43,298
-48% -$3.15M 1.06% 38
2020
Q4
$6.21M Buy
90,881
+2,233
+3% +$145K 2.01% 17
2020
Q3
$5.18M Buy
88,648
+2,533
+3% +$158K 1.93% 18
2020
Q2
$5.59M Buy
86,115
+3,197
+4% +$201K 2.28% 14
2020
Q1
$4.92M Buy
82,918
+1,998
+2% +$133K 2.46% 15
2019
Q4
$6.01M Sell
80,920
-7,415
-8% -$521K 2.52% 11
2019
Q3
$5.57M Sell
88,335
-9,142
-9% -$542K 2.65% 11
2019
Q2
$5.31M Buy
97,477
+12,313
+14% +$663K 2.59% 15
2019
Q1
$4.59M Buy
85,164
+18,152
+27% +$1.12M 2.19% 19
2018
Q4
$4.39M Sell
67,012
-346
-0.5% -$25.8K 2.19% 18
2018
Q3
$5.3M Buy
67,358
+2,877
+4% +$206K 2.3% 12
2018
Q2
$4.15M Buy
64,481
+3,471
+6% +$229K 1.91% 18
2018
Q1
$3.79M Buy
61,010
+21,916
+56% +$1.57M 1.79% 21
2017
Q4
$2.83M Sell
39,094
-3,388
-8% -$246K 1.41% 32
2017
Q3
$3.46M Buy
42,482
+956
+2% +$75.6K 1.74% 26
2017
Q2
$3.34M Buy
41,526
+1,776
+4% +$140K 1.79% 24
2017
Q1
$3.12M Buy
+39,750
New +$3.17M 1.73% 27

Other funds holding CVS

Valicenti Advisory Services's CVS Position: Q2 2021 in Review

Valicenti Advisory Services sold out of CVS Health (CVS) in Q2 2021, closing a stake of 47,583 shares — an estimated $3.58M sold.

Valicenti Advisory Services first reported a position in CVS in Q1 2017 and held it in 17 quarters. The position peaked at $6.21M in Q4 2020. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Valicenti Advisory Services reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • Valicenti Advisory Services sold 47,583 CVS Health shares in Q2 2021, an estimated $3.58M.
  • Valicenti Advisory Services first reported a position in CVS Health in Q1 2017 and held it in 17 quarters.
  • Valicenti Advisory Services's CVS Health position peaked at $6.21M in Q4 2020.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Valicenti Advisory Services's 13F filing for Q2 2021, filed 21 Jul 2021.